01
February 2024 Feb 2024
Posted February 01, 2024
Monash University Centre for Medicine Use and Safety investigators are urgently seeking expressions of interest from general practice clinics for this well-remunerated study to deliver tailored intervention or provide usual care in patients with chronic obstructive pulmonary disease (COPD).
‘Treatable traits’ (TTs) refers to individually assessing patients for a specified set of treatable problems, followed by the development and implementation of an individualised treatment programme. The aim of this research project is to evaluate the efficacy of a practice nurse-coordinated intervention - Targeting Treatable Traits in COPD to Prevent Hospitalisations (TERRACOTTA) – in the Australian primary care. The goal is to improve quality of life in patients with COPD and reduce hospitalisations.
In the TERRACOTTA trial, disease management targeting TT will be delivered by an interdisciplinary team of general practitioners (GPs), practice nurses, pharmacists, physiotherapists and other allied health professionals.
Click here for further information about the study. View Project Flyer and Explanatory Statement for GP Practices.
Contact Ingrid Sand, TERRACOTTA Project Manager. terracotta@monash.edu or phone: 0412 234 012 for further information.
Subscribe to our mailing list to get all the latest news updates delivered to your inbox.
This project will use co-design and deliberative approaches, bringing together publics, GPs, policy makers and regulators, to design a best practice framework for the use of general practice data for research purposes.
The ALIGNED study may help your patients with depression find the right antidepressant medication.
The purpose of this study is to report the presence of imposter syndrome (IS) in recently graduated AHPs, and to determine if there is an association between IS and AHPs geographic work location, through an online survey.